American Chemical Society Honors Brian Bidlingmeyer
American Chemical Society Honors Brian Bidlingmeyer
The American Chemical Society (ACS) named Brian Bidlingmeyer of Agilent Technologies, Inc. (Santa Clara, California) and a member of LCGC's editorial advisory board to the 2012 class of ACS Fellows, a prestigious honor bestowed upon 96 distinguished scientists who have demonstrated outstanding accomplishments in chemistry and made important contributions to ACS, the world's largest scientific society.
"These chemists hold the future to our country, to our way of life, and to the legacy we will leave for the next generation," said ACS President Bassam Z. Shakhashiri, PhD. "Whether it's producing renewable fuels, finding cures for afflictions such as diabetes, cancer, AIDS, and Alzheimer's disease, or ensuring safe drinking water, these Fellows are scientific leaders, improving our lives through the transforming power of chemistry."
The 2012 Fellows were recognized at an induction ceremony during the society's 244th National Meeting and Exposition in Philadelphia, Pennsylvania, where each Fellow received a lapel pin and a certificate.
The ACS Fellows program was created by the ACS Board of Directors in December 2008 "to recognize members of ACS for outstanding achievements in and contributions to science, the profession, and the society." Fellows are chosen from academe, industry, and government.
Agilent Partners with Sera Prognostics to Target Pregnancy Complications
Agilent Technologies and Sera Prognostics (Salt Lake City, Utah) have formed a strategic partnership to develop proteomic assays for the prediction of pregnancy complications. Sera Prognostics is a private biotechnology company that develops diagnostic tests for these risks.
"By providing pivotal information to physicians, Sera's preterm birth predictor is designed to address an unmet medical need for a reliable, early risk assessment that has the potential to help significantly improve the health of mothers and newborns, while materially reducing the costs of care," commented Gregory C. Critchfield, chairman and chief executive officer of Sera Prognostics. "Our partnership with Agilent provides Sera with access to advanced and innovative technologies designed to deliver on the promise of personalized medicine."
Through the partnership with Agilent, Sera Prognostics has purchased a number of liquid chromatography instruments. Furthermore, Sera Prognostics is adapting sample preparation technology from Agilent to meet the demands of high-volume testing.
"Agilent and Sera Prognostics share the vision of applying the power of advanced proteomic technologies to address meaningful medical challenges," said Yvonne Linney, vice president and general manager of Agilent's Life Science Solutions Division.
GC–TOF-MS Finds 250 Volatile Compounds in E-Cigarette Liquids
November 1st 2024A study has used gas chromatography coupled to a time-of-flight mass spectrometer to build an electron ionization mass spectra database of more than 250 chemicals classified as either volatile or semi-volatile compounds. An additional, confirmatory layer of liquid chromatography–mass spectrometry analysis was subsequently performed.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Multivariate Design of Experiments for Gas Chromatographic Analysis
November 1st 2024Recent advances in green chemistry have made multivariate experimental design popular in sample preparation development. This approach helps reduce the number of measurements and data for evaluation and can be useful for method development in gas chromatography.